ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 295500 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 295500; 2) Community: the network communities that were significantly associated with the response to NSC 295500; 3) Molecule: the relationships between components within communities and NSC 295500; 4) MDR: the compounds that were significantly associated with the NSC 295500.

NSC Compound Enrichment Correlation
NSC 606499 Camptothecin Derivative 0.00103112124545271 0.78844925
NSC 681632 Camptothecin Derivative 0.00103112124545271 0.80236256
NSC 681641 Camptothecin Derivative 0.00103112124545271 0.69180181
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.00103112124545271 0.75331364
NSC 606498 Camptothecin Derivative 0.00140570135773563 0.89514566
NSC 609699 Topotecan hydrochloride 0.00140570135773563 0.79598953
NSC 610459 Camptothecin Derivative 0.00140570135773563 0.83510715
NSC 653860 Null 0.00140570135773563 0.69474979
NSC 681639 Camptothecin Derivative 0.00140570135773563 0.79420551
NSC 687453 2-Propenoic acid, 3-[2,3-dihydro-2-(4-hydroxy- 3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)- 5-benzofuranyl]-, methyl ester, racemic mixture of NSC 674908 and NSC 674996 0.00140570135773563 0.3520149
Total:54  Current:2    [First] [Prev] [Next] [Last]